Premier Alternatives

Mission Therapeutics

Cambridge, United Kingdom · Founded 2011 · Privately Held (backing)

Operator of a pharmaceutical research and drug discovery company intended to facilitate the development of advanced medical treatments. Mission Therapeutics is based in Cambridge, United Kingdom and was founded in 2011. Its last reported valuation was $115 million in Mar 2024. It has raised $214 million.

Last reported valuation
$115.2M
Oct 2026
Priced at
—
Total raised
$213.8M
Last round
—

Mission Therapeutics key facts

as of Oct 2026
  • Operator of a pharmaceutical research and drug discovery company intended to facilitate the development of advanced medical treatments.
  • Mission Therapeutics is valued at approximately $115.2M as of Oct 2026 (last reported valuation).
  • It has raised $213.8M; the latest was Later Stage VC ($13.3M) in Oct 2025.
  • Notable investors include Innovate UK, Cambridge Enterprise Ventures, Sofinnova Partners, Pfizer Ventures, Revelation Partners — 17 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$115.2M

Mission Therapeutics's last reported valuation, Mar 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Mission Therapeutics with a free account
  • ·The complete investor list: 17 names
  • ·Watch Mission Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Mission Therapeutics funding rounds

No rounds on record

No funding rounds for Mission Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Mission Therapeutics valuation

Mission Therapeutics's last reported valuation was $115 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.

Mission Therapeutics investors

17 investors are on record for Mission Therapeutics, including Innovate UK, Cambridge Enterprise Ventures, Sofinnova Partners and Pfizer Ventures. By type, the record holds 4 venture capital firms and 1 family office.

About Mission Therapeutics

Operator of a pharmaceutical research and drug discovery company intended to facilitate the development of advanced medical treatments. The company specializes in the research and development of deubiquitylating enzymes and new molecular understandings of human cell biology into drugs that will improve the management of life-threatening diseases, particularly cancer, enabling healthcare professionals to treat unmet diseases.

Sector
Healthcare
HQ
Cambridge, United Kingdom
Founded
2011
Employees
14
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.